Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Resmed is looking to new innovations to give the sleep ...

Gift 5 articles to anyone you choose each month when you subscribe. Sleep apnea device maker ResMed will expand its American manufacturing operations and open a new facility in Indianapolis in 2027 ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

For my first rating of ResMed, I'm calling a buy, agreeing with today's consensus from Wall St. and more confident than the quant system, which said hold. Key upside factors are new business ...

Key financial ratios for Astral Ltd as of March 2025 include a basic EPS of Rs 19.50, a book value per share of Rs 134.46, and a return on equity of 14.48%. The debt to equity ratio is 0.04. As of ...

The ResMed Inc (ASX: RMD) share price is rising on Friday morning. At the time of writing, the sleep disorder treatment company's shares are up 2.5% to a record high of $43.47. This follows the ...

Revenue: $1.35 billion, a 10% increase year-over-year. Gross Margin: 61.4%, an expansion of 230 basis points year-over-year. Free Cash Flow: $1.7 billion for fiscal year 2025. Net Income: Increased by ...

Resmed announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the market closes. Following the release, management will ...

Coromandel Int has shown fluctuating revenues over the years, with a decrease to Rs 5,504 Cr in March 2025. The company has been reporting net losses, with a net profit of -Rs 789 Cr in March 2025.

The CEO of ResMed, a $49b company which manufactures sleep devices to treat sleep apnea and other chronic respiratory conditions, on Thursday revealed the Trump Administration will not apply tariffs ...